We've detected that Javascript is not enabled. It is required for an optimal survey taking experience.
Please check your browser's settings and make sure Javascript is turned on. Learn how to enable Javascript.

Skip survey header

9101 PAH Enduring Activity Jeopardy- Nathan King

PAH Enduring: Jeopardy with Steven Nathan, MD & Christopher King, MD

DEMOGRAPHICS

Other, please specify *This question is required.

LEARNER SELF ASSESSMENT

5. BEFORE taking this educational activity, how would you have rated your ability to: *This question is required.

Space Cell	0 - Not Relevant	1 - Low	2	3	4	5 - High
Accurately assess prognostic risk level for patients with PAH?	Accurately assess prognostic risk level for patients with PAH?: 0 - Not Relevant	Accurately assess prognostic risk level for patients with PAH?: 1 - Low	Accurately assess prognostic risk level for patients with PAH?: 2	Accurately assess prognostic risk level for patients with PAH?: 3	Accurately assess prognostic risk level for patients with PAH?: 4	Accurately assess prognostic risk level for patients with PAH?: 5 - High
Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 0 - Not Relevant	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 1 - Low	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 2	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 3	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 4	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 5 - High
Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 0 - Not Relevant	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 1 - Low	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 2	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 3	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 4	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 5 - High

6. AFTER taking this educational activity, how would you have rated your ability to: *This question is required.

Space Cell	0 - Not Relevant	1 - Low	2	3	4	5 - High
Accurately assess prognostic risk level for patients with PAH?	Accurately assess prognostic risk level for patients with PAH?: 0 - Not Relevant	Accurately assess prognostic risk level for patients with PAH?: 1 - Low	Accurately assess prognostic risk level for patients with PAH?: 2	Accurately assess prognostic risk level for patients with PAH?: 3	Accurately assess prognostic risk level for patients with PAH?: 4	Accurately assess prognostic risk level for patients with PAH?: 5 - High
Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 0 - Not Relevant	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 1 - Low	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 2	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 3	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 4	Discuss with colleagues strategies to effectively identify side effects, optimize therapy, and improve outcomes for patients with PAH?: 5 - High
Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 0 - Not Relevant	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 1 - Low	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 2	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 3	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 4	Your knowledge of the supporting evidence for initiating combination therapy in patients with PAH?: 5 - High